SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019887
Filing Date
2024-05-15
Accepted
2024-05-15 16:20:49
Documents
88
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 717080
2 ex10-1.htm EX-10.1 74985
3 ex10-4.htm EX-10.4 108483
4 ex10-5.htm EX-10.5 70352
5 ex31-1.htm EX-31.1 18841
6 ex31-2.htm EX-31.2 18798
7 ex32-1.htm EX-32.1 6992
8 ex32-2.htm EX-32.2 7071
  Complete submission text file 0001493152-24-019887.txt   5096584

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE xtnt-20240331.xsd EX-101.SCH 43194
10 XBRL CALCULATION FILE xtnt-20240331_cal.xml EX-101.CAL 76751
11 XBRL DEFINITION FILE xtnt-20240331_def.xml EX-101.DEF 153524
12 XBRL LABEL FILE xtnt-20240331_lab.xml EX-101.LAB 367427
13 XBRL PRESENTATION FILE xtnt-20240331_pre.xml EX-101.PRE 300605
91 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 559782
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 24951197
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)